Laddar...
Thrombotic microangiopathy associated with proteasome inhibitors
The ubiquitin proteasome pathway plays a key role in cell cycle, function and survival. Bortezomib (BTZ) and Carfilzomib (CFZ) are the first two inhibitors of the proteasome pathway, indicated in treatment of patients with multiple myeloma. In the past few years, there have been few case reports tha...
Sparad:
| I publikationen: | Clin Kidney J |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Oxford University Press
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4581378/ https://ncbi.nlm.nih.gov/pubmed/26413293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv059 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|